"One Aspirin a Day keeps Heart Disease Away" is old proverb listened and being practised by all most many doctors but In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability). Risk of dying from a range of causes, including cancer and heart disease, varied and will require further analysis and additional follow-up of study participants.
These initial findings from the Aspirin in Reducing Events in the Elderly (ASPREE) trial, partially supported by the National Institutes of Health, were published online on September 16, 2018, in three papers in The New England Journal of Medicine. ASPREE is an international, randomized, double-blind, placebo-controlled trial that enrolled 19,114 older…
